Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
about
The role of cardiovascular magnetic resonance in the assessment of severe aortic stenosis and in post-procedural evaluation following transcatheter aortic valve implantation and surgical aortic valve replacement.Diagnosis and management of patients with asymptomatic severe aortic stenosisMRI evaluation prior to Transcatheter Aortic Valve Implantation (TAVI): When to acquire and how to interpret.Single vs Dual Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation: A Systematic ReviewBeyond adding years to life: health-related quality-of-life and functional outcomes in patients with severe aortic valve stenosis at high surgical risk undergoing transcatheter aortic valve replacementTranscatheter aortic valve implantation in the elderly: who to refer?Advanced age and the clinical outcomes of transcatheter aortic valve implantationImpact of renal dysfunction on mid-term outcome after transcatheter aortic valve implantation: a systematic review and meta-analysisEchocardiographic imaging of procedural complications during balloon-expandable transcatheter aortic valve replacement.Role of Echocardiography Before Transcatheter Aortic Valve Implantation (TAVI)Limitations and difficulties of echocardiographic short-axis assessment of paravalvular leakage after corevalve transcatheter aortic valve implantation.European real world trans-catheter aortic valve implantation: systematic review and meta-analysis of European national registriesDoes the aortic annulus undergo conformational change throughout the cardiac cycle? A systematic reviewTranscatheter aortic valve replacement: current perspectives and future implicationsCT Angiography after 20 Years: A Transformation in Cardiovascular Disease Characterization Continues to AdvanceHeart disease and stroke statistics--2014 update: a report from the American Heart AssociationTranscatheter Aortic Valve Replacement in Lower Surgical Risk Patients: Review of Major Trials and Future Perspectives.Rationale and design of the Edwards SAPIEN-3 periprosthetic leakage evaluation versus Medtronic CoreValve in transfemoral aortic valve implantation (ELECT) trial : A randomised comparison of balloon-expandable versus self-expanding transcatheter aorIncidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis.Prediction of paravalvular leakage after transcatheter aortic valve implantation.Imaging to select and guide transcatheter aortic valve implantation.Quantitative assessment of paravalvular regurgitation following transcatheter aortic valve replacement.The role of cardiovascular magnetic resonance in stratifying paravalvular leak severity after transcatheter aortic valve replacement: an observational outcome study.Transthoracic delivery of large devices into the left ventricle through the right ventricle and interventricular septum: preclinical feasibility.Current management of calcific aortic stenosis.Left ventricular reverse remodeling after transcatheter aortic valve implantation: a cardiovascular magnetic resonance study.Multi-modality imaging of the aortic valve in the era of transcatheter aortic valve replacement: a guide for patient selection, valve selection, and valve delivery.Incidence, predictors, origin and prevention of early and late neurological events after transcatheter aortic valve implantation (TAVI): a comprehensive review of current data.Transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis of randomised and non-randomised trialsChallenges in cardiac device innovation: is neuroimaging an appropriate endpoint? Consensus from the 2013 Yale-UCL Cardiac Device Innovation Summit.Minimally Invasive Versus Conventional Aortic Valve Replacement: A Propensity-Matched Study From the UK National DataDiagnosis and management of valvular aortic stenosis.Incidence and implications of idiopathic thrombocytopenia following transcatheter aortic valve replacement with the Edwards Sapien(©) valves: a single center experience.Acquired thrombocytopenia after transcatheter aortic valve replacement: clinical correlates and association with outcomes.Predictors and clinical impact of pre-existing and acquired thrombocytopenia following transcatheter aortic valve replacement.Thromboinflammatory response and predictors of outcomes in patients undergoing transcatheter aortic valve replacement.The medically managed patient with severe symptomatic aortic stenosis in the TAVR era: Patient characteristics, reasons for medical management, and quality of shared decision making at heart valve treatment centers.Initial experience of two national centers in transcatheter aortic prosthesis implantation.Transcatheter aortic valve replacement-state of the art and a glimpse to the future: 'the Tailored Approach'Functional status and quality of life after transcatheter aortic valve replacement: a systematic review.
P2860
Q26739737-3185FB12-FABF-42C3-A1A5-8339271E2A98Q26765161-BF83766A-A86D-4B5E-A0C0-7B4D58B52577Q26766542-ADB3761E-256F-4AED-81D9-B298127010A4Q26799407-F55F79FF-CB3A-483B-A358-46FD7E7696E2Q26823669-B97A1C9C-BAE9-4AE3-BB44-F7059B5163A8Q26860176-8D6DA6B8-C2D3-4E4E-9067-423A06EE4569Q26999451-956EF5F5-8C22-40B9-B3B0-97CF8AF18FD8Q27008295-A594EDD6-99C0-44D4-918E-D1C57A252EA1Q27310075-2B1BA87C-ACE5-4669-8603-D20309D54B89Q28075179-4B46ABEC-9263-4157-9354-AC677422519BQ28075918-ECC2936F-2380-41F1-907B-9E4B5C4602B4Q28078840-DC67070C-4D37-48FD-9A63-5637F7E76F4DQ28085017-7B5BEB77-3DBE-432A-88E6-46085FA3D3F9Q28251808-2D40B273-5AEB-43F2-9E13-1DD4F1BAC4C1Q29039498-3FDBD6D4-3F32-432A-AFD9-A01B42A95FBDQ29547691-EA5FEA6C-912D-4B02-81FC-9CF4EEE9AB4DQ30275988-26E9F404-9639-4CC1-8A1D-8453DA3E4218Q30356932-51F52A02-3D65-4EC1-B68E-A16C069C6380Q30370788-4EBB82B5-5FF8-4D8B-B493-C8B6EB660446Q30402553-F22C1BC5-8996-4DB9-A85D-1D74AB5AA56DQ30408890-6DB9167E-B088-404D-AA16-C86EDB2A4D68Q30412154-DA8D4B1A-2C63-4332-83DF-BEECABBACE7BQ30423461-E827BF1D-572E-4407-9E54-74D3574EA677Q30430166-D0C64E29-CAE5-468C-BF5C-1B0E3F1867ECQ30435363-16AE84A4-68DD-4884-94BE-3CF522E973E5Q30453765-AC3488B4-9BE9-4C5C-86C4-65D5EB459806Q30456881-48922498-FB6D-43C4-BA69-86F9777B58BBQ30584743-340749FC-B8FC-4864-8D1D-B93EDB5F71DBQ30589893-8312F967-5567-43AE-AE0A-5B83E0AAA906Q30713413-68549D14-3A8D-45FC-996F-244255BE4BFCQ31050235-1D786581-1B52-48EB-B181-563A6E4D42BDQ33164920-087CD8FF-D157-4D57-9BB5-07C0B30AE177Q33410910-7BADEA88-7235-41E4-825D-6CD4C035A726Q33413684-9DAF4500-0A9E-4A5E-B301-8D44B7DF7751Q33417579-F9AA3E2F-DC64-4633-A30B-DA63DF347E19Q33428988-1A28C34D-97B7-433E-965C-0475FE6CD37FQ33590311-540726C9-D957-43BE-8D85-5A72485E1757Q33641522-D2658150-23B3-42E8-83A3-1F7385545FF3Q33646856-0790B910-CC85-4412-A037-73BBB4D3CDC7Q33688018-A2197484-67F9-495D-8389-A5E5FB0BD458
P2860
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
description
article
@en
im Mai 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2012
@uk
name
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
@en
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
@nl
type
label
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
@en
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
@nl
prefLabel
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
@en
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
@nl
P2093
P50
P356
P1476
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
@en
P2093
Alan Zajarias
Augusto D. Pichard
Brian Whisenant
Craig R. Smith
Duolao Wang
Gregory P. Fontana
Jodi J. Akin
John G. Webb
Kevin L. Greason
Lars G. Svensson
P304
P356
10.1056/NEJMOA1200384
P407
P577
2012-05-03T00:00:00Z